These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3985214)

  • 1. Opioids, dopamine, and restless legs syndrome.
    Gillman MA; Sandyk R
    Am J Psychiatry; 1985 May; 142(5):662. PubMed ID: 3985214
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine and the spinal cord in restless legs syndrome: does spinal cord physiology reveal a basis for augmentation?
    Paulus W; Schomburg ED
    Sleep Med Rev; 2006 Jun; 10(3):185-96. PubMed ID: 16762808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [L-dopa, dopamine agonists, opiates... what calms down restless legs].
    Wepner U
    MMW Fortschr Med; 2005 Feb; 147(8):6, 8. PubMed ID: 18437857
    [No Abstract]   [Full Text] [Related]  

  • 4. Transient restless legs-like syndrome as a complication of opiate withrawal.
    Scherbaum N; Stüper B; Bonnet U; Gastpar M
    Pharmacopsychiatry; 2003; 36(2):70-2. PubMed ID: 12734764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine agonist-induced pathological gambling in restless legs syndrome due to multiple sclerosis.
    Evans AH; Butzkueven H
    Mov Disord; 2007 Mar; 22(4):590-1. PubMed ID: 17230484
    [No Abstract]   [Full Text] [Related]  

  • 6. [Restless legs, restless nights: therapeutic options in RLS].
    Kassubek J; Unrath A
    MMW Fortschr Med; 2009 Mar; 151(13):65-7, 69. PubMed ID: 19504823
    [No Abstract]   [Full Text] [Related]  

  • 7. Restless legs syndrome and Parkinson's disease: insights into pathophysiology.
    Lang AE
    Clin Neuropharmacol; 1987 Oct; 10(5):476-8. PubMed ID: 3503686
    [No Abstract]   [Full Text] [Related]  

  • 8. Dyskinesias while awake and periodic movements in sleep in restless legs syndrome: treatment with opioids.
    Hening WA; Walters A; Kavey N; Gidro-Frank S; Côté L; Fahn S
    Neurology; 1986 Oct; 36(10):1363-6. PubMed ID: 3762946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of the restless legs syndrome].
    Zeitlhofer J
    MMW Fortschr Med; 2008 May; 150 Suppl 2():77-9. PubMed ID: 18678059
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term effect of dopaminergic drugs in restless legs. A 2-year follow-up.
    von Scheele C; Kempi V
    Arch Neurol; 1990 Nov; 47(11):1223-4. PubMed ID: 1978661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restless legs syndrome.
    Neurology; 1987 Aug; 37(8):1436-7. PubMed ID: 3614681
    [No Abstract]   [Full Text] [Related]  

  • 12. [Restless leg syndrome].
    Winkelmann J; Collado-Seidel V; Trenkwalder C
    Med Monatsschr Pharm; 1999 Mar; 22(3):67-71. PubMed ID: 10097580
    [No Abstract]   [Full Text] [Related]  

  • 13. [Patient complains about sleep disorders: place "restless legs" therein].
    Eisensehr I; Karlbauer G; Storck K
    MMW Fortschr Med; 2005 Oct; 147(43):62-3. PubMed ID: 16302428
    [No Abstract]   [Full Text] [Related]  

  • 14. Review and videotape recognition of idiopathic restless legs syndrome.
    Walters AS; Hening WA; Chokroverty S
    Mov Disord; 1991; 6(2):105-10. PubMed ID: 1676135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of the restless leg syndrome with or without periodic leg movements in sleep.
    Montplaisir J; Lapierre O; Warnes H; Pelletier G
    Sleep; 1992 Oct; 15(5):391-5. PubMed ID: 1360697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restless legs syndrome treatment with dopaminergic drugs.
    Akpinar S
    Clin Neuropharmacol; 1987; 10(1):69-79. PubMed ID: 3545461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic treatment in idiopathic restless legs syndrome: effects on subjective sleepiness.
    Kallweit U; Khatami R; Pizza F; Mathis J; Bassetti CL
    Clin Neuropharmacol; 2010; 33(6):276-8. PubMed ID: 21060282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Six months treatment of restless legs syndrome with levodopa/benserazide in domiciliary practice].
    Mühlau G
    MMW Fortschr Med; 2004 Dec; 146(Suppl 3-4):87-93. PubMed ID: 15662897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome.
    Paulus W; Trenkwalder C
    Lancet Neurol; 2006 Oct; 5(10):878-86. PubMed ID: 16987735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic treatment of restless legs and rebound phenomenon.
    Guilleminault C; Cetel M; Philip P
    Neurology; 1993 Feb; 43(2):445. PubMed ID: 8094897
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.